Factorial Partners, LLC Gilead Sciences, Inc. Transaction History

Factorial Partners, LLC

$156 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$76.01 - $86.7 $1.06 Million - $1.21 Million	14,000 New	14,000 $1.08 Million
Q3 2022 Nov 04, 2022	BUY	$59.54 - $68.01 $178,620 - $204,030	3,000 Added 16.39%	21,300 $1.31 Million
Q2 2022 Aug 03, 2022	BUY	$57.72 - $65.01 $92,352 - $104,016	1,600 Added 9.58%	18,300 $1.13 Million
Q1 2022 May 03, 2022	BUY	$57.92 - $72.58 $167,968 - $210,482	2,900 Added 21.01%	16,700 $993,000
Q4 2021 Feb 09, 2022	SELL	$64.88 - $73.64 $843,439 - $957,320	-13,000 Reduced 48.51%	13,800 $1 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $338,450 - $365,150	-5,000 Reduced 15.72%	26,800 $1.87 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $209,451 - $228,854	3,300 Added 11.58%	31,800 $2.19 Million
Q1 2021 May 21, 2021	SELL	$60.0 - $68.46 $109 Million - $124 Million	-1,813,455 Reduced 98.45%	28,500 $1.84 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $108 Million - $124 Million	1,806,955 Added 5162.73%	1,841,955 $28.5 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $1.05 Million - $1.2 Million	18,600 Added 113.41%	35,000 $2.04 Billion
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $6,210 - $7,808	-100 Reduced 0.61%	16,400 $1.04 Billion
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $1.63 Million - $1.89 Million	-22,500 Reduced 57.69%	16,500 $1.27 Billion
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $300,624 - $385,056	-4,800 Reduced 10.96%	39,000 $2.92 Billion
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $135,564 - $149,116	2,200 Added 5.29%	43,800 $2.85 Billion
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $31,255 - $34,500	500 Added 1.22%	41,600 $2.64 Billion
Q2 2019 Aug 15, 2019	BUY	$61.87 - $69.38 $383,594 - $430,156	6,200 Added 17.77%	41,100 $2.78 Billion
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $912,938 - $1.02 Million	14,600 Added 71.92%	34,900 $2.27 Billion
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $30,270 - $39,500	500 Added 2.53%	20,300 $1.27 Billion
Q3 2018 Nov 08, 2018	SELL	$71.28 - $78.92 $199,584 - $220,976	-2,800 Reduced 12.39%	19,800 $1.53 Billion
Q2 2018 Aug 01, 2018	BUY	$64.88 - $75.68 $986,175 - $1.15 Million	15,200 Added 205.41%	22,600 $1.6 Billion
Q1 2018 Apr 23, 2018	SELL	$72.84 - $88.8 $1.76 Million - $2.14 Million	-24,100 Reduced 76.51%	7,400 $558 Million
Q4 2017 Apr 19, 2018	BUY	$71.15 - $83.52 $2.24 Million - $2.63 Million	31,500	31,500 $2.26 Billion

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Factorial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Factorial Partners, LLC with notifications on news.

Account